CHF

Monitor BP, monitor for hypotension, assess for s/s of peripheral neuritis (Vallerand et al., 2015).

"Management of HF in black patients"
(Vallerand et. al, 2015)

Prophylaxis treatment for
atrial fibrillation

Assessment: Assess for s/s of bleeding, bruising, tarry stools, BP, guaiac-positive stools, urine, and fall of hematocrit, assess for thrombosis, monitor labs for PT, INR (Vallerand et al., 2015).

Assessment: Monitor BP, pulse, ECG, respiratory rate, cardiac index, central venous pressure, hypotension, I&O, assess for signs of HF, assess for s/s of allergic reaction (Vallerand et al., 2015).

For Acutely decompensated HF in hospitalized patients who have dyspnea at rest or with minimal activity (Vallerand et al., 2015).

Was Discontinued 11/2/16, @ 1430, TO,RB, per nurse Sara, per Doctor Smith

Assessment: Monitor apical pulse for full minute before admin, withhold if <60bmp, monitor BP in IV admin, monitor ECG throughout admin, observe IV site. Monitor I&O, auscultate lung sounds (Vallerand et al., 2015).

For "Heart failure. Atrial fibrillation and atrial flutter (slows ventricular rate). Paroxysmal atrial tachycardia". (Vallerand et al., 2015).

Assessment: Assess for N/V, abdominal distention, and bowel sounds prior to admin. Assess for extrapyramidal effects, monitor ECG, and for s/s of serotonin syndrome (Vallerand et al., 2015).

Prevention of nausea and vomiting associated with highly or moderately emetogenic chemotherapy (Vallerand et al., 2015).

Assessment: Monitor BP and pulse frequently, weight and assess for fluid overload (edema, rales/crackles, dyspnea, JVD), monitor BUN, creatinine, and electrolyte levels (Vallerand et al., 2015).

Antihypertensive, for management of HF (Vallerand et. al, 2015)

Antihypertensive, for HF

Assessment: Monitor BP and pulse frequently, weight and assess for fluid overload (edema, rales/crackles, dyspnea, JVD), monitor BUN, creatinine, and electrolyte levels. Assess for orthostatic hypotension (Vallerand et al., 2015).

Assessment: Monitor I&O, assess BP before admin, assess for hyperkalemia s/s and labs, periodic ECGs, assess skin for rash, SJ-syndrome, or toxic epidermal necrolysis (Vallerand et al., 2015).

For management of edema from HF
(Vallerand et. al, 2015)

Assessment: Monitor ECG, heart rate and rhythm, assess pacing and defibrillation threshold, assess for signs of pulmonary toxicity (rales/crackles, wheezes, hypoxia, decreased breath sounds), monitor BP, neurotoxicity, thyroid dysfunction, liver dysfunction, and weight gain (Vallerand et al., 2015).

For “Life-threatening ventricular arrhythmias unresponsive to less toxic agents” (Vallerand et al., 2015).

Non-rebreather

An oxygen administration device with one-way valves for inspiration and expiration and a reservoir bag, used to attain high concentrations of oxygen (Vallerand et. al, 2015)

Foley Catheter

A urinary tract catheter with a balloon attachment at one end. After the catheter is inserted, the balloon is inflated. Thus the catheter is prevented from leaving the bladder until the balloon is emptied (Vallerand et. al, 2015)